13F

FTLF FITLIFE BRANDS INC

2026Q1 · CUSIP 33817P405 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
41
Δ holders QoQ
-2
Breadth percentile
Top 70%
Whale holders
27
Δ whales
0
Inst. holding value
$12M
New positions
9
Closed positions
11
Price momentum (1Q)
Put / Call
0/0

Breadth history (34 quarters)

2025Q2: Δ+8 · h=31 2025Q3: Δ+4 · h=35 2025Q4: Δ+8 · h=43 2026Q1: Δ-2 · h=41 2025Q2: holders=31 2025Q3: holders=35 2025Q4: holders=43 2026Q1: holders=41 -8 -4 +0 +4 +8 273746 25Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
18.7
EPS (TTM)
$0.60
EPS YoY
-33.3%
Revenue (TTM)
$0.1B
Revenue YoY
+42.3%
Quarterly Revenue & EPS (4Y)
2022-06-30: $8M 2022-09-30: $8M 2022-12-31: $5M 2023-03-31: $11M 2023-06-30: $15M 2023-09-30: $14M 2023-12-31: $13M 2024-03-31: $17M 2024-06-30: $17M 2024-09-30: $16M 2024-12-31: $15M 2025-03-31: $16M 2025-06-30: $16M 2025-09-30: $23M 2025-12-31: $26M 2026-03-31: $25M 2024-03-31: EPS 0.21 2024-06-30: EPS 0.27 2024-09-30: EPS 0.21 2024-12-31: EPS 0.22 2025-03-31: EPS 0.20 2025-06-30: EPS 0.18 2025-09-30: EPS 0.09 2025-12-31: EPS 0.16 2026-03-31: EPS 0.17 0M 13M 26M $M 0.00 0.15 0.30 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 21 2024-12-31: PE 16.62025-03-31: PE 15.22025-06-30: PE 20.52025-09-30: PE 26.22025-12-31: PE 22.62026-03-31: PE 17.5 14 21 28 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)